SELF SAMPLING KITS
Self-Sampling
Test
Chlamydia Test Kit for Women
At-home screening for Chlamydia trachomatis based on a self-collected vaginal swab specimen.
Samples are analysed by a certified laboratory.
Chlamydia trachomatis infection is frequently asymptomatic, particularly in women, and may remain undetected in the absence of routine screening. Persistent untreated infection is associated with adverse reproductive health outcomes. Molecular testing constitutes an established component of evidence based screening strategies for the early identification of infection and appropriate clinical follow up.
This product is intended for screening and risk assessment purposes only and is not designed to diagnose disease or replace clinician directed care pathways.
Available soon — Greece only (Phase 1).
Detailed information regarding analytical performance characteristics, intended use, limitations, and procedural requirements will be provided upon official product launch.
Cervical Health (HPV) Kit
At-home screening for high risk Human Papillomavirus (HPV) based on a self collected vaginal swab specimen.
Samples are analysed by a certified laboratory using laboratory based HPV DNA testing with the cobas® HPV Test by Roche. The cobas® HPV Test is approved by the U.S. Food and Drug Administration (FDA) and is widely used in organised cervical screening programmes.
Persistent infection with high risk HPV types is the established etiological factor in the development of cervical cancer. Molecular HPV DNA testing constitutes a core component of contemporary cervical cancer screening strategies, supporting early risk stratification and evidence based clinical management in accordance with European public health guidance.
This product is intended for screening and risk assessment purposes only and is not designed to diagnose cervical cancer or replace clinician directed screening pathways.
Available soon — Greece only (Phase 1).
Detailed information regarding clinical performance characteristics, analytical validity, intended use, limitations, and procedural requirements will be provided upon official product launch.